NM_000218.3:c.574C>T
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM5PP3_Moderate
The NM_000218.3(KCNQ1):c.574C>T(p.Arg192Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000124 in 1,611,772 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R192H) has been classified as Pathogenic.
Frequency
Consequence
NM_000218.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNQ1 | ENST00000155840.12 | c.574C>T | p.Arg192Cys | missense_variant | Exon 3 of 16 | 1 | NM_000218.3 | ENSP00000155840.2 | ||
KCNQ1 | ENST00000335475.6 | c.193C>T | p.Arg65Cys | missense_variant | Exon 3 of 16 | 1 | ENSP00000334497.5 | |||
KCNQ1 | ENST00000496887.7 | c.313C>T | p.Arg105Cys | missense_variant | Exon 4 of 16 | 5 | ENSP00000434560.2 | |||
KCNQ1 | ENST00000646564.2 | c.478-12711C>T | intron_variant | Intron 2 of 10 | ENSP00000495806.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152188Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000401 AC: 10AN: 249252Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135164
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1459584Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 10AN XY: 726212
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152188Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74340
ClinVar
Submissions by phenotype
Long QT syndrome Uncertain:2
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 192 of the KCNQ1 protein (p.Arg192Cys). This variant is present in population databases (rs775059928, gnomAD 0.05%). This missense change has been observed in individual(s) with long QT syndrome (LQTS) (PMID: 22629021, 23631430, 28606196, 28704380). ClinVar contains an entry for this variant (Variation ID: 578178). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KCNQ1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects KCNQ1 function (PMID: 24947509, 30571187). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This missense variant replaces arginine with cysteine at codon 192 of the KCNQ1 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). A functional study has shown that the current of the mutant channel was significantly decreased upon PIP2 injection, indicating an impaired functional interaction with PIP2 (PMID: 24947509). This variant has been reported in one individual affected with long QT syndrome (PMID: 28606196), one individual with Romano-Ward syndrome (PMID: 22629021), one individual with suspected long QT syndrome (PMID: 23631430), and one case with sudden unexpected death syndrome (PMID: 28704380). This variant has been identified in 11/280628 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Pathogenic. The p.Arg192Cys variant in KCNQ1 has been reported in 1 heterozygous individual and 2 compound heterozygous individuals with long QT syndrome (LQTS), and one case with sudden death (Gao 2012, Lieve 2013, McLeod 2017, Suktitipat 2017). None of the compound heterozygous individuals had hearing loss. This variant has been identified in 0.05% (9/18834) of East Asian chromosomes by the Genome Aggregation Database (gn omAD, http://gnomad.broadinstitute.org). Computational prediction tools and cons ervation analysis suggest that the p.Arg192Cys variant may impact the protein, t hough this information is not predictive enough to determine pathogenicity. In s ummary, while there is some suspicion for a pathogenic role, the clinical signif icance of the p.Arg192Cys variant is uncertain. ACMG/AMP criteria applied: PS4_S upporting, PM2_Supporting, PP3. -
Beckwith-Wiedemann syndrome;C1837014:Atrial fibrillation, familial, 3;C1865019:Short QT syndrome type 2;C4551509:Jervell and Lange-Nielsen syndrome 1;C4551647:Long QT syndrome 1 Uncertain:1
- -
Cardiovascular phenotype Uncertain:1
The p.R192C variant (also known as c.574C>T), located in coding exon 3 of the KCNQ1 gene, results from a C to T substitution at nucleotide position 574. The arginine at codon 192 is replaced by cysteine, an amino acid with highly dissimilar properties. This variant was reported in conjunction with a KCNE1 variant and in trans with KCNQ1 c.1032G>A in an individual with Romano Ward syndrome; this variant was also identified in the proband's unaffected mother (Gao Y et al. J Cardiovasc Dis Res, 2012 Apr;3:67-75). This variant was identified in a long QT syndrome (LQTS) cohort (Lieve KV et al. Genet Test Mol Biomarkers, 2013 Jul;17:553-61), in a sudden death victim in conjunction with a variant in DSP (Suktitipat B et al. PLoS ONE, 2017 Jul;12:e0180056), and in an individual with LQTS in conjunction with KCNQ1 p.G179S (McLeod KA et al. Cardiol Young, 2017 Sep;27:1271-1279). Function studies in Xenopus oocytes demonstrated an increased current, whereas studies in CHO cells demonstrated a reduced current (Eckey K et al. J. Biol. Chem., 2014 Aug;289:22749-58; Vanoye CG et al. Circ Genom Precis Med, 2018 11;11:e002345). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Cardiac arrhythmia Uncertain:1
This missense variant replaces arginine with cysteine at codon 192 of the KCNQ1 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). A functional study has shown that the current of the mutant channel was significantly decreased upon PIP2 injection, indicating an impaired functional interaction with PIP2 (PMID: 24947509). This variant has been reported in individuals affected with or suspected of having long QT syndrome, epilepsy, arrhythmia, sudden unexpected death syndrome, or other diseases (PMID: 22629021, 23631430, 28704380, 28606196, 31696929). This variant has been identified in 11/280628 chromosomes (10/19916 East Asian chromosomes) in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at